Article

Even after years research, there's no conclusive evidence of efficacy or safety in treating acute back pain.

The U.S. Food and Drug Administration decision makes GSK’s shot, called Arexvy, the first of several potential vaccines in the pipeline for RSV to be licensed anywhere.

When an organization can change the rules in its favour—and undermine the wishes of members in the process—we should all be greatly concerned.

Update from the American College of Gastroenterology aimed at supporting clinical practice.

Research shows that Americans, who have become less engaged with worship houses, community organizations and even their own family members in recent decades, have steadily reported an increase in feelings of loneliness.

Alberta NDP Leader Rachel Notley says healthcare has deteriorated badly under the United Conservatives, leaving as many as 800,000 Albertans without a family doctor.

The RESTORE Network is working with a specialized group of experts on clinical trials, testing new therapies and technologies to improve the quality of life for those with neurological disorders.